Clinical trials sponsored by National Cancer Center, Korea

Phase breakdown

Conditions studied

Recruiting trials led by National Cancer Center, Korea

• A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
  NCT06156527 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 5 locations
• Prospective Study of Ultrahypofractionated Proton Beam Therapy for Localized Prostate Cancer
  NCT07699705 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: Male · 1 location
• Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy
  NCT06780735 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers
  NCT06135896 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is National Cancer Center, Korea recruiting for?

National Cancer Center, Korea is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.